Minnesota Epilepsy Group is a clinical research site located in Roseville, Minnesota, United States.
Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.
Minnesota Epilepsy Group has participated in 3 clinical trials with 1 currently active.
Therapeutic areas: Tuberous Sclerosis, Lymphangioleiomyomatosis, Epilepsy.
Sponsors: National Tuberous Sclerosis Association, Stanford University, Jazz Pharmaceuticals.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Minnesota · View every site in Roseville
Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Minnesota Epilepsy Group has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Minnesota Epilepsy Group has 3 clinical trials on record, with 1 currently active. Their work covers Tuberous Sclerosis, Lymphangioleiomyomatosis, Epilepsy.
Minnesota Epilepsy Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.